Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC353121 in stem cell transplant recipients with RSV upper respiratory tract infection
2006-003439-53Phase 2Completed
- Sponsor
- Tibotec
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus disease (RSV) comparing TMC353121 with Placebo (2 arms). Started Sep 2006; status: completed.
02
Drugs
TMC353121
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on 2006-003439-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003439-53.